IDEAYA Biosciences, Inc. IDYA Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s accrued expenses and other liabilities?
- IDEAYA Biosciences, Inc. (IDYA) reported accrued expenses and other liabilities of $2.73M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s accrued expenses and other liabilities changed year-over-year?
- IDEAYA Biosciences, Inc.'s accrued expenses and other liabilities decreased by 5.1% year-over-year, from $2.88M to $2.73M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s accrued expenses and other liabilities?
- Over 3 years (2021 to 2024), IDEAYA Biosciences, Inc.'s accrued expenses and other liabilities has grown at a 36.8% compound annual growth rate (CAGR), from $4.21M to $10.79M.